Status:

RECRUITING

Same-day Radioembolization for Large HCC

Lead Sponsor:

Seoul National University Hospital

Conditions:

Hepatocellular Carcinoma (HCC)

Eligibility:

All Genders

19+ years

Brief Summary

In patients who has no sign suggesting high lung shunt fraction (TIPS, hepatic vein invasion, hepatic vein enhancement on arterial phase, dysmorphic intratumoral vessel), planning angiography, MAA sca...

Detailed Description

SIR-Spheres (SIRTEX): A mother vial containing ≥7 GBq is delivered to the hospital, and the treatment team divides it into daughter vials with specific radiation activities tailored to the target vess...

Eligibility Criteria

Inclusion

  • HCC can be diagnosed by AASLD guideline
  • hepatocellular carcinoma 5cm or larger
  • dysmorphic intratumoral vessels 3mm or smaller
  • Child-Pugh class A
  • ECOG 0 or 1
  • the following lab should be met. A. Leukocytes ≥ 1,000/µL and ≤ 20,000/µL B. Hemoglobin ≥ 6.0 g/dL (transfusion allowed to meet this criterion) C. Total bilirubin ≤ 2.0 mg/dL D. Platelet ≥ 40,000/µL E. International normalized ratio (INR) ≤ 2.0 for patients not taking anticoagulants F. Aspartate transaminase (AST) ≤ 800 IU/L (i.e., ≤ 20X upper normal limit) G. Alanine transaminase (ALT) ≤ 800 IU/L (i.e., ≤ 20X upper normal limit) H. Creatinine ≤ 2.5 mg/dL (if patient is receiving hemodialysis, no upper limit of creatinine)

Exclusion

  • hepatic vein invasion on CT/MRI
  • hepatic vein enhancement on arterial phase of CT/MRI
  • TIPS
  • dysmorphic intratumoral vessels \> 3mm
  • main portal vein invasion
  • significant COPD or interstitial lung disease
  • biliary stent or enterobiliary anastomosis

Key Trial Info

Start Date :

April 25 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2029

Estimated Enrollment :

138 Patients enrolled

Trial Details

Trial ID

NCT06944483

Start Date

April 25 2025

End Date

December 31 2029

Last Update

July 16 2025

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

National Cancer Center

Goyang, South Korea

2

Samsung Medical Center

Seoul, South Korea

3

Seoul National University Hospital

Seoul, South Korea

4

Severance hospital

Seoul, South Korea